Pelvital: Women’s Health Company Closes $2.32 Million
By Amit Chowdhry ● Yesterday at 2:13 AM
Pelvital, a leading women's health company, announced the successful closing of an additional $2.32 million in its seed-plus funding round, closing the round out $500,000 oversubscribed at $5 million. The seed plus funding will be used to expedite the commercialization of Flyte, which Pelvital's novel FDA-cleared revolutionary, accessible, and clinically proven treatment for stress urinary incontinence (SUI) and weakened pelvic floor muscles.